Navigation Links
Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
Date:2/13/2008

BRISBANE, Australia, Feb. 13 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA) today announced positive preliminary efficacy results from a phase 2 investigator-initiated trial of PI-88 in combination with the chemotherapeutic agent Taxotere(R) (docetaxel) administered to patients with prostate cancer. Dr. Gavin Marx, Royal North Shore Hospital, Sydney Haematology and Oncology Clinics, the principal investigator conducting the trial, will present the preliminary results of the study today at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium in San Francisco.

The investigator-initiated study was a randomized two-arm open-label study design that assessed efficacy and safety of two dose schedules (4 days/week and 7 days/week) of subcutaneous PI-88 in combination with three-weekly Taxotere(R) (75 mg/m2, IV on day 1). The study comprised a lead-in phase 1 safety component to establish the maximum tolerated dose (MTD) of PI-88 at each of the two dosing schedules, followed by a randomized phase 2 component expanding the two dose schedule.

70% of the 55 patients recruited to the trial had a decrease in serum Prostate Specific Antigen (PSA) of greater than 50% for three weeks or longer. These efficacy results compare favourably with the pivotal TAX327 Taxotere(R) registration trial, where 45% of patients had at least a 50% decrease in serum PSA level(1). PSA is a substance produced in the prostate gland, a high level of which may indicate the presence of cancer. In patients with advanced prostate cancer, many clinicians use increasing levels of PSA as an indicator of disease progression.

The trial concluded enrollment early due to a higher-than-expected rate of febrile neutropaenia, a side effect involving a decrease in white blood cells with associated fever. This is a known side effect of Taxotere(R), but was seen in this trial at a substantially greater rate than is generally c
'/>"/>

SOURCE Progen Pharmaceuticals Limited
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
3. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
4. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
5. Pharmion and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting
8. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
9. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
10. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
11. A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... NEW YORK , June 18, 2013 /PRNewswire/ ... BDX ) are accelerating the development of new products ... through a new collaboration announced today. This new, three-year commitment ... 1 diabetes (T1D). Many patients with T1D not ... a catheter to be placed in the body for a ...
(Date:6/18/2013)... 2013 Remedy Informatics, a leading provider ... sciences research, today announced it has been awarded ... 70 supply contract (GS-35F-367AA, effective May 7, 2013) ... solutions to government agencies at federal, state and ... has placed its products and services on the ...
(Date:6/18/2013)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ), the ... a general corporate update in conjunction with its 2013 Annual ... at 2:10 p.m. Pacific Time in Carlsbad, CA. ... as follows: 2:00 p.m. – 2:10 p.m. Annual Meeting of ... 2013) 2:10 p.m. – 3:15 p.m. Corporate Presentation – ...
Breaking Medicine Technology:JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2
... leading provider of prescription drug monitoring services and education to ... company,s founder and CEO James Slattery has been ... Entrepreneur Of The Year® 2011 Award for the San Diego ... 165 nominations by a panel of independent judges. The ...
... BEIJING, April 22, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: ... in China, announced today it has filed its Annual Report ... for the year ended December 31, 2010 on April 22, ... on www.sec.gov . The Company will provide ...
Cached Medicine Technology:Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year® 2011 Award Semifinalist in San Diego 2Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year® 2011 Award Semifinalist in San Diego 3Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year® 2011 Award Semifinalist in San Diego 4Sinovac Files Annual Report on Form 20-F 2
(Date:6/18/2013)... CA (PRWEB) June 19, 2013 oBand ... bariatric surgery, are holding complimentary weight loss seminars in ... detailed program can be accessed at their official website. ... surgery and recovery time. Their highly skilled panel of ... bariatric surgery. , A senior executive working with ...
(Date:6/18/2013)... 2013 Recent studies linking bullying and depression, ... among young people, led the Centers for Disease ... panel to focus on these issues. This panel ... between youth involvement in bullying and suicide-related behaviors. ... a significant public health problem, with widespread and ...
(Date:6/18/2013)... York, NY (PRWEB) June 18, 2013 Cheap ... tickets for the tournament which gets underway in July. ... savings on any CONCACAF ticket order. , The ... and cranny of the globe.    In fact, the hype of the ... Its popularity also trickled down the veins of fans ...
(Date:6/18/2013)... The Drug Delivery Partnering Terms and ... the drug delivery partnering deals and agreements entered into ... report provides a detailed understanding and analysis of how ... majority of deals are discovery or development stage whereby ... to license the license drug delivery technology. These deals ...
(Date:6/18/2013)... ENT and Allergy Associates, LLP (ENTA) ... the opposite. , New York/New Jersey’s premier ear, ... trained physicians offering superior healthcare to children and adults ... Greater New York area-only considers adding to its current ... that includes the right communities to serve, the right ...
Breaking Medicine News(10 mins):Health News:oBand Surgery Centers Will Hold Complimentary Weight Loss Seminars in Los Angeles in June 2Health News:Bullying and suicide among youth is a public health problem 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 2Health News:CONCACAF Tickets Have Been Released for Martinique, Mexico, Panama, El Salvador, Trinidad, Tobago, Haiti, Honduras, Costa Rica, Cuba, Belize, US, Canada, Honduras & Cuba 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 2Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 3Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 4Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 5
... One hormone cured 80 percent of pancreatic cancers, two-thirds ... (HealthDay News) -- New research offers early evidence that ... pressure and volume could be harnessed to treat -- ... , Following a month of intravenous treatment with any ...
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer ... that Michael Dale, President and CEO of,ATS Medical, ... Rodman & Renshaw,"Straight to the Heart" conference at ... Attendance at the conference is by invitation only. ...
... Pharmos Corporation,(Nasdaq: PARS ) today reported financial results for ... Fourth Quarter Ended December 31, 2007, For the ... of $2.7 million, or $0.11 per share compared to a ... same period in 2006. The substantial,decrease in net loss is ...
... NewYork-Presbyterian Hospital/Weill Cornell Medical Center announced today that Ronald ... has made a $50 million gift to the Medical ... Weill Cornell Medical College, in support of health care ... gift will establish the Ronald O. Perelman Heart Institute, ...
... addition to other cosmetic procedures, FREDERICKSBURG, Va., ... pleased to announce that Dr. Todd P. Ginestra ... currently booking appointments for Dr. Ginestra, who,will offer ... In addition, Dr. Ginestra will perform cosmetic procedures ...
... and activities, PITTSBURGH, Feb. 28 Highmark ... through its Employee Volunteer,Grant Program, an initiative designed ... who know first-hand the most,pressing needs of the ... are awarded to nonprofit organizations,with which Highmark employees ...
Cached Medicine News:Health News:Heart Hormones Beat Back Cancers in Mice 2Health News:Heart Hormones Beat Back Cancers in Mice 3Health News:Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results 2Health News:Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results 3Health News:Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results 4Health News:Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results 5Health News:Pharmos Corporation Reports 2007 Fourth Quarter and Year-end Results 6Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 2Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 3Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 4Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 5Health News:Plastic Surgeon Joins Established Practice 2Health News:Highmark Inc. Supports Employee Volunteerism Efforts with $5,500 in Community Grants 2Health News:Highmark Inc. Supports Employee Volunteerism Efforts with $5,500 in Community Grants 3Health News:Highmark Inc. Supports Employee Volunteerism Efforts with $5,500 in Community Grants 4Health News:Highmark Inc. Supports Employee Volunteerism Efforts with $5,500 in Community Grants 5
... optimize the accuracy and precision of Finnpipettes. ... widely recognized by customers throughout the world. ... the years and now covers a full ... filter tips, certified pure tips, stepper tips ...
... all Gilson disposable pipette tips, ... sterilized version. Each Sterilized TowerPack ... device-quality plastic to help protect ... guaranteed by the red sticker, ...
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
... Finntip Filters are ideal ... methods, or for any work ... They are designed for pipetting ... samples, and other. For applications ...
Medicine Products: